Laura Andromalos, MS, RD, RN, CDCES, has worked from coast to coast as a dietitian, diabetes educator, and nutrition manager since 2009, specializing in weight management, specifically metabolic and bariatric surgery (MBS). In 2022, Laura expanded her scope by becoming a nurse. She is a bilingual labor and delivery nurse at Hennepin Healthcare in Minneapolis, MN, where she combines her dual disciplines to support the health of women and newborns.

Laura holds a BS in Nutrition Sciences from Cornell University, a MS in Health Communication from Boston University, and a MS in Nursing from Capella University. She volunteers in several professional organizations and has presented at conferences around the world. Outside of work, Laura is a flying trapeze artist and an avid traveler with her husband, Mike, and pup, Bandit. In 2024, she welcomed her first child, Gino, who she hopes will love circus and travel as well.

Mary-Elizabeth Patti, MD, is a physician-scientist and adult endocrinologist at Joslin Diabetes Center, Director of the Hypoglycemia Clinic, and Associate Professor of Medicine at Harvard Medical School. Dr. Patti’s NIH-funded laboratory studies focus on identification of molecular and epigenetic mechanisms by which environmental/nutritional factors during early life confer metabolic disease risk in later life and in subsequent generations. Her clinical/translational studies focus on the intestine as a mediator of systemic glucose metabolism and novel approaches to treatment of post-bariatric hypoglycemia.  

Dr. Patti received her MD from Jefferson Medical College, graduating magna cum laude. She completed her internal medicine residency at the University of Pittsburgh and her endocrinology fellowship at Harvard Medical School. Outside of work, Dr. Patti is the proud mom of three children, five cats, and one dog.

Disclosures: 

Mary Elizabeth Patti, MD, faculty for this event, has the following relevant financial relationship(s) with ineligible companies to disclose: she received an investigator-initiated research grant from Dexcom; she is a member of the Data Safety Monitoring Board of Fractyl; she received grants from National Institutes of Health; she is a consultant for Spruce Biosciences; and she serves as a site investigator for Recordati and Amylyx. All relevant financial relationships listed for this individual have been mitigated.

Laura Andromalos, MS, RD, RN, CDCES, faculty, and the planners for this educational activity have no relevant financial relationship(s) with ineligible companies to disclose.

An “ineligible company” includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.